The Effect of Vırtual Realıty Glasses on Heart Faılure Patıents
ConditionHeart Failure
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBayburt University
About this trial
Anxiety and sleep disorders are among the most common symptoms in heart failure patients. In addition to pharmacological methods for anxiety and sleep disorders, non-pharmacological methods can also be used. Among these, anxiety and sleep disorders can be prevented with virtual reality glasses aimed at distraction. This study will be conducted to evaluate the effect of breathing exercises performed with virtual reality glasses on anxiety, sleep quality, and respiratory parameters. The study will be conducted with a total of 45 patients, 15 virtual reality glasses + breathing exercises, 15 breathing exercises, and 15 controls. Those in the virtual reality glasses + breathing exercises group will perform breathing exercises with virtual reality glasses once a day for 7 days. Those in the breathing exercises group will perform only breathing exercises once a day for 7 days. Anxiety, sleep disorders, and respiratory parameters of the patients will be examined.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years of age or older,
Verbal communication,
Place and time oriented,
Without any psychiatric illness,
Disqualifiers
Life signs are so abnormal as to preclude intervention,
Patients with migraine, vertigo, active nausea-vomiting, headache, dizziness will not be included in the study.
Trial design
Design model
Parallel
Treatments tested in this trial
Virtual reality glasses
Behavioralvirtual reality glasses application
breathing exercise
Behavioralbreathing exercise app
Treatment groups
45 Participants
are divided into 3 treatment groupsGroup A: Virtual reality glasses + breathing exercise appExperimental treatment 2 interventions
Group B: Breathing exercise practiceActive comparator 1 intervention
Group C: KontrolNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Anxiety level
Turkish adaptation of the state-trait anxiety inventory short version (STAIS-5, STAIT-5). This form is a 4-point Likert type. It is an easy-to-apply inventory consisting of a total of 10 statements. As the score obtained in this form increases, the level of anxiety also increases.
Time frame
Apply the morning before application and the morning 7 days after application.Secondary outcomes
1
Sleep Quality
Richard Campbell Sleep Quality Scale (RCSQ) for sleep quality level assessment.This form is a 6-item scale. According to the scale scoring, a score between "0-25" indicates very poor sleep, and a score between "76-100" indicates very good sleep.
Time frame
Apply the morning before application and the morning 7 days after application.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: